Salarius Pharmaceuticals, Inc. Quarterly General and Administrative Expense in USD from Q1 2014 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Salarius Pharmaceuticals, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q1 2014 to Q2 2025.
  • Salarius Pharmaceuticals, Inc. General and Administrative Expense for the quarter ending June 30, 2025 was $849K, a 32.2% decline year-over-year.
  • Salarius Pharmaceuticals, Inc. General and Administrative Expense for the twelve months ending June 30, 2025 was $4.67M, a 9.89% decline year-over-year.
  • Salarius Pharmaceuticals, Inc. annual General and Administrative Expense for 2024 was $4.96M, a 13.2% decline from 2023.
  • Salarius Pharmaceuticals, Inc. annual General and Administrative Expense for 2023 was $5.72M, a 19.9% decline from 2022.
  • Salarius Pharmaceuticals, Inc. annual General and Administrative Expense for 2022 was $7.14M, a 16.9% increase from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $849K -$404K -32.2% Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $1.64M +$115K +7.49% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $1.31M +$403K +44.2% Dec 31, 2024 10-K 2025-03-21
Q3 2024 $869K -$627K -41.9% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.25M -$366K -22.6% Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $1.53M -$166K -9.82% Mar 31, 2024 10-Q 2025-05-14
Q4 2023 $911K -$881K -49.2% Dec 31, 2023 10-K 2025-03-21
Q3 2023 $1.5M -$336K -18.4% Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $1.62M -$217K -11.8% Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $1.7M +$17.3K +1.03% Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $1.79M +$343K +23.7% Dec 31, 2022 10-K 2024-03-22
Q3 2022 $1.83M +$101K +5.85% Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.84M +$244K +15.4% Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.68M +$345K +25.9% Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.45M +$236K +19.5% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $1.73M +$398K +29.8% Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.59M -$109K -6.41% Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $1.33M -$526K -28.3% Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.21M -$548K -31.1% Dec 31, 2020 10-K 2022-03-25
Q3 2020 $1.33M -$2.16M -61.8% Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.7M +$733K +75.8% Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $1.86M +$371K +24.9% Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $1.76M -$161K -8.37% Dec 31, 2019 10-K 2021-03-18
Q3 2019 $3.49M +$3.07M +715% Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $968K -$2.03M -67.7% Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $1.49M -$2.21M -59.7% Mar 31, 2019 10-Q/A 2020-05-15
Q4 2018 $1.92M -$2.06M -51.8% Dec 31, 2018 10-K 2019-03-06
Q3 2018 $429K -$4.51M -91.3% Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $2.99M -$2M -40% Jun 30, 2018 10-Q 2019-07-17
Q1 2018 $3.7M -$897K -19.5% Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $3.98M +$64.4K +1.64% Dec 31, 2017 10-K 2019-03-06
Q3 2017 $4.93M -$513K -9.42% Sep 30, 2017 10-K 2019-03-06
Q2 2017 $4.99M -$387K -7.19% Jun 30, 2017 10-K 2019-03-06
Q1 2017 $4.59M -$517K -10.1% Mar 31, 2017 10-K 2019-03-06
Q4 2016 $3.92M -$703K -15.2% Dec 31, 2016 10-K 2018-03-07
Q3 2016 $5.45M +$726K +15.4% Sep 30, 2016 10-K 2018-03-07
Q2 2016 $5.38M +$1.47M +37.7% Jun 30, 2016 10-K 2018-03-07
Q1 2016 $5.11M +$1.9M +58.9% Mar 31, 2016 10-K 2018-03-07
Q4 2015 $4.62M +$2.84M +159% Dec 31, 2015 10-K 2017-03-08
Q3 2015 $4.72M +$3.64M +336% Sep 30, 2015 10-K 2017-03-08
Q2 2015 $3.9M +$2.81M +257% Jun 30, 2015 10-K 2017-03-08
Q1 2015 $3.22M +$3.15M +5030% Mar 31, 2015 10-K 2017-03-08
Q4 2014 $1.79M Dec 31, 2014 10-K 2016-03-08
Q3 2014 $1.08M Sep 30, 2014 10-K 2016-03-08
Q2 2014 $1.09M Jun 30, 2014 10-K 2016-03-08
Q1 2014 $62.7K Mar 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.